Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Insogna

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Blood|August 8, 2009
Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone diseaseAnjli Kukreja, Soroosh Radfar, Ben-Hua Sun, et al.
Biological Research for Nursing|August 19, 2008
An aerobic weight-loaded pilot exercise intervention for breast cancer survivors: bone remodeling and body composition outcomesM Tish Knobf, Karl Insogna, Loretta DiPietro, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Torus palatinus: a new anatomical correlation with bone density in postmenopausal womenJoseph L Belsky, Josephine S Hamer, Janet E Hubert, et al.
Plos One|February 19, 2021
Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimenMeiling Zhu, Ben-Hua Sun, Erin Nevius, et al.
Calcified Tissue International|November 27, 2010
Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activityTakashi Itokowa, Mei-ling Zhu, Nancy Troiano, et al.
Bone|September 5, 2006
Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclastsHiroaki Sakai, Yan Chen, Takashi Itokawa, et al.
Bone Reports|March 21, 2020
Corrigendum to "Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutation" [Bone Rep. 9 (2018) 154-158]Kathleen Timme, Elizabeth Sanchez Rangel, Qianying Yuan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2002
Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidismInaam A Nakchbandi, Mary Ann Mitnick, Robert Lang, et al.
Bone Reports|October 27, 2018
Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutationKathleen Ang, Elizabeth Sanchez Rangel, Qianying Yuan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 18, 2007
Breast cancer-associated gene 3 (BCA3) is a novel Rac1-interacting proteinKuan-ping Yu, Takashi Itokawa, Mei-ling Zhu, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Blood|August 8, 2009
Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone diseaseAnjli Kukreja, Soroosh Radfar, Ben-Hua Sun, et al.
Biological Research for Nursing|August 19, 2008
An aerobic weight-loaded pilot exercise intervention for breast cancer survivors: bone remodeling and body composition outcomesM Tish Knobf, Karl Insogna, Loretta DiPietro, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Torus palatinus: a new anatomical correlation with bone density in postmenopausal womenJoseph L Belsky, Josephine S Hamer, Janet E Hubert, et al.
Plos One|February 19, 2021
Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimenMeiling Zhu, Ben-Hua Sun, Erin Nevius, et al.
Calcified Tissue International|November 27, 2010
Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activityTakashi Itokowa, Mei-ling Zhu, Nancy Troiano, et al.
Bone|September 5, 2006
Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclastsHiroaki Sakai, Yan Chen, Takashi Itokawa, et al.
Bone Reports|March 21, 2020
Corrigendum to "Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutation" [Bone Rep. 9 (2018) 154-158]Kathleen Timme, Elizabeth Sanchez Rangel, Qianying Yuan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2002
Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidismInaam A Nakchbandi, Mary Ann Mitnick, Robert Lang, et al.
Bone Reports|October 27, 2018
Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutationKathleen Ang, Elizabeth Sanchez Rangel, Qianying Yuan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 18, 2007
Breast cancer-associated gene 3 (BCA3) is a novel Rac1-interacting proteinKuan-ping Yu, Takashi Itokawa, Mei-ling Zhu, et al.
Pageof 6